Skip to main content

Table 1 Study population and participant characteristics

From: Effect of cardiopulmonary bypass reoxygenation on myocardial dysfunction following pediatric tetralogy of Fallot repair

 

Total

Lower PpO2 (163)

Higher PpO2 (213)

P value

Baseline clinical variables

    

Age at surgery, month

23.3 (12.5–39.4)

22.77 (12.9–39.4)

24.60 (12.4–38.8)

0.975

Sex, %

   

< 0.001

 Female

164 (43.6%)

55 (33.7%)

109 (51.2%)

 

 Male

212 (56.4%)

108 (66.3%)

104 (48.8%)

 

Body mass index, %

15.59 (14.3–16.9)

15.60 (14.3–16.8)

15.58 (14.3–16.8)

0.974

Hematocrit, %

41.7 (37.4–48.5)

40.70 (37.0–47.0)

42.90 (38.1–49.6)

0.141

SpO2, %

84.0 (77.7–93.0)

86.00 (78.5–95.0)

82.0 (77.0–92.0)

0.004

NYHA class

   

0.670

 I–II

353 (93.9%)

152 (93.3%)

201 (94.4%)

 

 III–IV

23 (6.1%)

11 (6.8%)

12 (5.6%)

 

LVEDV index, ml/m2

27.02 (19.96–35.66)

29.00 (22.59–36.88)

25.84 (18.84–34.63)

0.014

Pulmonary annular z-score

    

 < − 4.0, %

101 (26.9%)

50 (30.7%)

51 (23.9%)

0.048

 − 2.0 to − 4.0, %

117 (31.1%)

40 (24.5%)

77 (36.2%)

 

 > − 2.0, %

158 (42.0%)

73 (44.8%)

85 (39.9%)

 

McGoon index

    

 ≤ 1.5, %

138 (37.1%)

54 (33.5%)

84 (39.8%)

0.215

 > 1.5, %

234 (62.9%)

107 (66.5%)

127 (60.2%)

 

APCAS, %

   

0.828

 None-minimal (untreated)

187 (49.9%)

84 (51.5%)

103 (48.6%)

 

 Minor (untreated)

79 (21.1%)

34 (20.9%)

45 (21.2%)

 

 Major (treated)

109 (29.1%)

45 (27.6%)

64 (30.2%)

 

Procedural variables

    

Cardioplegia, %

   

0.500

 4:1 (Buckberg)

129 (34.3%)

59 (36.2%)

70 (32.9%)

 

 1:4 (del Nido)

247 (65.7%)

104 (63.8%)

143 (67.1%)

 

Transannular patch, %

   

0.880

 Absence

165 (44.0%)

71 (43.6%)

94 (44.3%)

 

 Presence

210 (56.0%)

92 (56.4%)

118 (55.7%)

 

Tricuspid valve detachment, %

   

0.461

 Absence

304 (80.8%)

129 (79.1%)

175 (82.2%)

 

 Presence

72 (19.2%)

34 (20.9%)

38 (17.8%)

 

Blood transfusion, %

   

0.017

 < 10 ml per kg

60 (16.0%)

27 (16.6%)

33 (15.5%)

 

 10–30 ml per kg

121 (32.2%)

56 (34.4%)

65 (30.5%)

 

 > 30 ml per kg

195 (51.8%)

80 (49.0%)

115 (54.0%)

 

Post-CVP, %

   

0.530

 5–10 cmH2O

274 (72.9%)

123 (75.5%)

151 (71.0%)

 

 < 5 cmH2O

30 (8.0%)

13 (8.0%)

17 (7.9%)

 

 > 10 cmH2O

72 (19.2%)

27 (16.5%)

45 (21.1%)

 

Post-TPG, %

   

0.643

 < 15 mmHg

99 (26.3%)

46 (28.2%)

53 (24.9%)

 

 15–30 mmHg

160 (42.6%)

70 (42.9%)

90 (42.2%)

 

 > 30 mmHg

117 (31.1%)

47 (28.8%)

70 (32.9%)

 

CPB time, min

123.5(90.0–158.5)

116.0 (88.5–143.0)

131.0 (92.0–169.0)

0.013

  1. Continuous data are presented as median (IQR) and dichotomous data are presented as counts (%). PpO2 = perfusate oxygenation; SpO2 = percutaneous oxyhemoglobin saturation; LVEDV = left ventricular end-diastolic volume; APCAS = aortopulmonary collateral arteries; CPB = cardiopulmonary bypass; post-CVP = immediately postoperative central venous pressure; post-TPG = immediately postoperative transpulmonary gradient